Despite extensive progress in understanding the pathology of Alzheimer's disease (AD) over
the last 50 years, clinical trials based on the amyloid–beta (Aβ) hypothesis have kept failing …

Alzheimer's disease is the most common neurodegenerative disease. Until now, there has
been no specific medicine that can cure Alzheimer's disease or effectively reverse the …

There is growing interest in the production of foods and beverages with nutrient and
nutraceutical profiles tailored to an individual's specific nutritional requirements. In principle …

AD is a chronic neurodegenerative disease. Many different signaling pathways, such as
Wnt/β-catenin, Notch, ROS/JNK, and PI3K/Akt/mTOR are involved in Alzheimer's disease …

Since health care systems dedicate substantial resources to Alzheimer's disease (AD), it
poses an increasing challenge to scientists and health care providers worldwide, especially …

Alzheimer's disease (AD) is recognized as a major health hazard that mostly affects people
older than 60 years. AD is one of the biggest medical, economic, and social concerns to …

Alzheimer's disease (AD) is a neurodegenerative disorder characterised by impairments in
the cognitive domains associated with orientation, recording, and memory. This pathology …

A new epoch is emerging with intense research on nutraceuticals, ie,“food or food product
that provides medical or health benefits including the prevention and treatment of diseases” …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive
memory loss and cognitive decline. Although substantial research has been conducted to …

Mercury (Hg), which is a non-essential element, is considered a highly toxic pollutant for
biological systems even when present at trace levels. Elevated Hg exposure with the …